08/15/2024 3:27 PM | Blueprint Medicines (Subject) Landsittel Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024 4:06 PM | Blueprint Medicines (Issuer) Lee Philina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 3:50 PM | Blueprint Medicines (Subject) Lee Philina (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024 3:48 PM | Blueprint Medicines (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024 6:29 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/08/2024 6:07 PM | Blueprint Medicines (Issuer) Rossi Christina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/08/2024 6:08 PM | Blueprint Medicines (Issuer) Carter Percy H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/21/2024 4:54 PM | Blueprint Medicines (Subject) Durso-Bumpus Debra (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2024 3:36 PM | Blueprint Medicines (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/14/2024 4:32 PM | Blueprint Medicines (Issuer) Dable Habib J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:32 PM | Blueprint Medicines (Issuer) Borisy Alexis (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:34 PM | Blueprint Medicines (Issuer) Goldberg Mark Alan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:34 PM | Blueprint Medicines (Issuer) Lydon Nicholas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:35 PM | Blueprint Medicines (Issuer) Seely Lynn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:36 PM | Blueprint Medicines (Issuer) Tsai John (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:37 PM | Blueprint Medicines (Issuer) COATS LONNEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:38 PM | Beckman Daniella (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:41 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:11 PM | Blueprint Medicines (Subject) Carter Percy H. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024 3:40 PM | Blueprint Medicines (Subject) Hewes L. Becker (Reporting) Hewes L. Becker (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024 3:38 PM | Blueprint Medicines (Subject) Hewes L. Becker (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024 7:00 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/06/2024 4:19 PM | Blueprint Medicines (Issuer) Hurley Ariel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/06/2024 4:26 PM | Blueprint Medicines (Issuer) Landsittel Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 3:43 PM | Blueprint Medicines (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024 6:09 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/02/2024 6:09 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/25/2024 4:24 PM | Blueprint Medicines (Filer)
| Form DEF 14A | |
04/25/2024 4:25 PM | Blueprint Medicines (Filer)
| Form ARS | |
04/25/2024 7:30 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 11:58 AM | Blueprint Medicines (Subject) PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A | |
03/28/2024 4:57 PM | Blueprint Medicines (Subject) Landsittel Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024 8:11 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:50 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:22 PM | Blueprint Medicines (Subject) Landsittel Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 3:46 PM | Blueprint Medicines (Subject) Hurley Ariel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 3:47 PM | Blueprint Medicines (Issuer) Lee Philina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:17 PM | Blueprint Medicines (Subject) Lee Philina (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 5:24 PM | Blueprint Medicines (Issuer) Murray Christopher K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:26 PM | Blueprint Medicines (Issuer) Lee Philina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:27 PM | Blueprint Medicines (Issuer) Haviland Kate (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
What is Nvidia’s New $1 Trillion SuperProject? (Ad) Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%.
Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9285&Placement=NativeDisplay&Source=NativeDisplay) Find out details on these three critical Nvidia partners immediately. |
03/11/2024 5:28 PM | Blueprint Medicines (Issuer) Durso-Bumpus Debra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:29 PM | Blueprint Medicines (Issuer) Hewes L. Becker (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:15 PM | Blueprint Medicines (Issuer) Hurley Ariel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:18 PM | Blueprint Medicines (Issuer) McCain Tracey L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:19 PM | Blueprint Medicines (Issuer) Carter Percy H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:20 PM | Blueprint Medicines (Issuer) Namouni Fouad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:21 PM | Blueprint Medicines (Issuer) Rossi Christina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:23 PM | Blueprint Medicines (Issuer) Landsittel Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:22 PM | Blueprint Medicines (Issuer) Lee Philina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:15 PM | Blueprint Medicines (Issuer) Hurley Ariel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:16 PM | Blueprint Medicines (Issuer) Carter Percy H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:17 PM | Blueprint Medicines (Issuer) Landsittel Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:18 PM | Blueprint Medicines (Issuer) Haviland Kate (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:19 PM | Blueprint Medicines (Issuer) Hewes L. Becker (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:20 PM | Blueprint Medicines (Issuer) Rossi Christina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:20 PM | Blueprint Medicines (Issuer) Durso-Bumpus Debra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:21 PM | Blueprint Medicines (Issuer) Namouni Fouad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 9:41 AM | Blueprint Medicines (Issuer) Murray Christopher K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 5:19 PM | Blueprint Medicines (Subject) Murray Christopher K. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 2:06 PM | Blueprint Medicines (Issuer) Murray Christopher K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 3:03 PM | Blueprint Medicines (Subject) Murray Christopher K. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024 7:20 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 3:40 PM | Blueprint Medicines (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/15/2024 4:26 PM | Blueprint Medicines (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2024 6:05 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 5:54 PM | Blueprint Medicines (Issuer) Lee Philina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:35 AM | Blueprint Medicines (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
01/29/2024 5:13 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 8:46 AM | BlackRock Inc. (Filed by) Blueprint Medicines (Subject)
| Form SC 13G/A | |
01/10/2024 9:16 AM | Blueprint Medicines (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
01/08/2024 7:03 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/26/2023 3:24 PM | Blueprint Medicines (Issuer) Hurley Ariel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 2:56 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 5:09 PM | Blueprint Medicines (Subject) Murray Christopher K. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 7:45 PM | Blueprint Medicines (Issuer) Murray Christopher K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 12:17 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023 8:02 AM | Blueprint Medicines (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
10/30/2023 1:01 PM | Blueprint Medicines (Issuer) Murray Christopher K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/26/2023 6:00 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/05/2023 9:47 AM | Blueprint Medicines (Issuer) Namouni Fouad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/29/2023 1:36 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |